As many as 10% of the 20 million Am...

As many as 10% of the 20 million Americans who rely in succession daily aspirin to prevent heart attacks and hits may not benefit from aspirin therapy because of their resistance to the medication's anticlotting power according to a March 19 2003 recents release from the American community of Cardiology Foundation. From January 1997 to September 1999 researchers from the Cleveland Clinic Foundation studied 326 participants with a history of cardiovascular disease. Normal aspirin therapy doses range from 81 mg to 162 mg daily; however, consideration participants took 325 mg of aspirin for at least united week before their blood was proofed Seventeen participants (5.2%) were originate to be resistant to aspirin's clotting tenor During a two-year follow-up period, these participants were more than three times as likely to die or stomach from a heart attack or thump than aspirin-responsive participants (ie, 24% versus 10%)

generally it is difficult and expensive to disguise patients for aspirin resistance and prescribe alternative therapies. For example, clopidogrel can be prescribed for patients who are aspirin resistant; however, this treatment require to be paid [i]or[/i] undergones $2 to $3 per day compared to single pennies for aspirin. Until the cause of aspirin resistance can be pinpointed or newer, les expensive screening rules are developed, physicians should continue to prescribe aspirin therapy for individuals at high risk for cardiovascular events

Aspirin Resistance Linked to Higher Rates of Heart Attack and misfortune (news re/ease, Bethesda, Md.. American literary institution [i]or[/i] seminary of learning of Cardiology Foundation, March 19 2003) http://www.acc.org/media/releases/highlights/2003/mar03/aspirin.htm (accessed 3 April 2003)

COPYRIGHT 2003 Association of Operating compass Nurses, Inc.

COPYRIGHT 2003 Gale Group